Ugurlu S - Search Results

1

Severity scores, damage indices and the concept of the colchicine-resistant patient in familial Mediterranean fever.

Er O, Akay H, Ozgozen ME, Gulhan D, Ugurlu S. Er O, et al. Among authors: ugurlu s. Mod Rheumatol. 2024 Aug 9:roae067. doi: 10.1093/mr/roae067. Online ahead of print. Mod Rheumatol. 2024. PMID: 39119678

2

Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.

Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Seyahi E, et al. Among authors: ugurlu s. Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S99-103. Clin Exp Rheumatol. 2006. PMID: 17067437 Clinical Trial.

3

Fever in Behçet's syndrome.

Seyahi E, Karaaslan H, Ugurlu S, Yazici H. Seyahi E, et al. Among authors: ugurlu s. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):64-7. Epub 2013 Sep 9. Clin Exp Rheumatol. 2013. PMID: 24064017

4

Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial.

Hamuryudan V, Hatemi G, Tascilar K, Yurdakul S, Mat C, Ozyazgan Y, Seyahi E, Ugurlu S, Yazici H. Hamuryudan V, et al. Among authors: ugurlu s. J Rheumatol. 2014 Apr;41(4):735-8. doi: 10.3899/jrheum.130847. Epub 2014 Feb 15. J Rheumatol. 2014. PMID: 24532830 Clinical Trial.

5

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.

Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S. Gül A, et al. Among authors: ugurlu s. Arthritis Res Ther. 2015 Sep 4;17(1):243. doi: 10.1186/s13075-015-0765-4. Arthritis Res Ther. 2015. PMID: 26337145 Free PMC article. Clinical Trial.

6

Canakinumab for the treatment of familial Mediterranean fever.

Ozdogan H, Ugurlu S. Ozdogan H, et al. Among authors: ugurlu s. Expert Rev Clin Immunol. 2017 May;13(5):393-404. doi: 10.1080/1744666X.2017.1313116. Epub 2017 Apr 10. Expert Rev Clin Immunol. 2017. PMID: 28362189 Review.

7

Familial Mediterranean Fever.

Ozdogan H, Ugurlu S. Ozdogan H, et al. Among authors: ugurlu s. Presse Med. 2019 Feb;48(1 Pt 2):e61-e76. doi: 10.1016/j.lpm.2018.08.014. Epub 2019 Jan 25. Presse Med. 2019. PMID: 30686512 Review.

8

Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey.

Erdogan M, Ugurlu S, Ozdogan H, Seyahi E. Erdogan M, et al. Among authors: ugurlu s. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):119-124. Epub 2019 Oct 29. Clin Exp Rheumatol. 2019. PMID: 31694753 Free article.

9

Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.

Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H. Ugurlu S, et al. Rheumatology (Oxford). 2020 Dec 1;59(12):3892-3899. doi: 10.1093/rheumatology/keaa211. Rheumatology (Oxford). 2020. PMID: 32556219

10

The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis.

Ozdogan H, Ugurlu S, Uygunoglu U, Tutuncu M, Gul A, Akman G, Siva A. Ozdogan H, et al. Among authors: ugurlu s. Mult Scler Relat Disord. 2020 Oct;45:102332. doi: 10.1016/j.msard.2020.102332. Epub 2020 Jun 24. Mult Scler Relat Disord. 2020. PMID: 32645635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters